Ir para o conteúdo principal

Grafa News and Videos — Page 1109

Destaques de Grafa

Grafa

AVITA Medical interim results show significant reduction in skin grafting timelines

AVITA Medical (NASDAQ:RCEL) announced on Tuesday, April 14, 2026, positive interim results from its Cohealyx-I clinical study, demonstrating that its dermal matrix significantly accelerates the timeline for skin grafting in complex wounds.

Leia mais: AVITA Medical interim results show significant reduction in skin grafting timelines
Grafa

Clearmind Medicine hits primary safety endpoint in Phase I/IIa alcohol use disorder trial

Clearmind Medicine (NASDAQ:CMND), a clinical-stage biopharmaceutical company focused on neuro-therapeutics, announced on Tuesday, April 14, 2026, that its lead oral candidate, CMND-100, successfully met the primary safety and tolerability endpoints in an FDA-approved Phase I/IIa dose-escalation trial.

Leia mais: Clearmind Medicine hits primary safety endpoint in Phase I/IIa alcohol use disorder trial

GARANTA JÁ SEU GRAFA EDGE

Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas